{"id":"https://openalex.org/W2005809501","doi":"https://doi.org/10.3892/ijo.23.1.213","title":"Evaluation of MDR1, LRP, MRP, and topoisomerase II\u03b1 gene mRNA transcripts before and after interferon-\u03b1, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines","display_name":"Evaluation of MDR1, LRP, MRP, and topoisomerase II\u03b1 gene mRNA transcripts before and after interferon-\u03b1, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines","alternate_titles":[],"publication_year":2003,"publication_date":"2003-07-01","ids":{"openalex":"https://openalex.org/W2005809501","doi":"https://doi.org/10.3892/ijo.23.1.213","mag":"2005809501","pmid":"https://pubmed.ncbi.nlm.nih.gov/12792796"},"language":"en","primary_location":{"id":"doi:10.3892/ijo.23.1.213","doi":"https://doi.org/10.3892/ijo.23.1.213","is_oa":false,"landing_page_url":"https://doi.org/10.3892/ijo.23.1.213","pdf_url":null,"source":{"id":"https://openalex.org/S4210208883","display_name":"International Journal of Oncology","issn_l":"1019-6439","issn":["1019-6439","1791-2423"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["dongbi-d","jufo-1","medline","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320412","host_organization_name":"Spandidos Publishing","host_organization_lineage":["https://openalex.org/P4310320412"],"host_organization_lineage_names":["Spandidos Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005809501"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071612095","display_name":"Clelia Miracco","orcid":"https://orcid.org/0000-0001-7642-7404","observed_orcids":["https://orcid.org/0000-0001-7642-7404"]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Clelia Miracco","raw_affiliation_strings":["Istituto di Anatomia e Istologia Patologica, Policlinico Le Scotte, I-53100 Siena, Italy. miracco@unisi.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto di Anatomia e Istologia Patologica, Policlinico Le Scotte, I-53100 Siena, Italy. miracco@unisi.it","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027752557","display_name":"Emilia Maellaro","orcid":"https://orcid.org/0000-0003-4865-8867","observed_orcids":["https://orcid.org/0000-0003-4865-8867"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emilia Maellaro","raw_affiliation_strings":["Ist. di Anat. e Istologia Patologica"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ist. di Anat. e Istologia Patologica","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087620595","display_name":"Lorenzo Pacenti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lorenzo Pacenti","raw_affiliation_strings":["Ist. di Anat. e Istologia Patologica"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ist. di Anat. e Istologia Patologica","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Barbara Del Bello","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Barbara Del Bello","raw_affiliation_strings":["Ist. di Anat. e Istologia Patologica"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ist. di Anat. e Istologia Patologica","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111852697","display_name":"Marta Valentini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marta Valentini","raw_affiliation_strings":["Ist. di Anat. e Istologia Patologica"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ist. di Anat. e Istologia Patologica","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075131381","display_name":"Pietro Rubegni","orcid":"https://orcid.org/0000-0002-7762-9312","observed_orcids":["https://orcid.org/0000-0002-7762-9312","https://orcid.org/0000-0001-7156-416X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pietro Rubegni","raw_affiliation_strings":["Ist. di Anat. e Istologia Patologica"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ist. di Anat. e Istologia Patologica","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066343209","display_name":"Luigi Pirtoli","orcid":"https://orcid.org/0000-0003-3037-4209","observed_orcids":["https://orcid.org/0000-0003-3037-4209","https://orcid.org/0009-0007-0680-1158"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luigi Pirtoli","raw_affiliation_strings":["Ist. di Anat. e Istologia Patologica"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ist. di Anat. e Istologia Patologica","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047241638","display_name":"Chiara Costanza Volpi","orcid":"https://orcid.org/0000-0002-8306-6851","observed_orcids":["https://orcid.org/0000-0002-8306-6851"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Chiara Volpi","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079734992","display_name":"Rosa Santopietro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rosa Santopietro","raw_affiliation_strings":["Ist. di Anat. e Istologia Patologica"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ist. di Anat. e Istologia Patologica","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111803662","display_name":"Piero Tosi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Piero Tosi","raw_affiliation_strings":["Ist. di Anat. e Istologia Patologica"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ist. di Anat. e Istologia Patologica","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1663,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.51697681,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"23","issue":"1","first_page":"213","last_page":"220"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9667999744415283,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9667999744415283,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10937","display_name":"Telomeres, Telomerase, and Senescence","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.8600000143051147},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.7310000061988831},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.9829999804496765},{"id":"https://openalex.org/keywords/mdr1","display_name":"MDR1","score":0.843999981880188},{"id":"https://openalex.org/keywords/mrp","display_name":"MRP","score":0.7160000205039978},{"id":"https://openalex.org/keywords/lung-resistance-protein","display_name":"lung resistance protein","score":0.8999999761581421},{"id":"https://openalex.org/keywords/topoisomerase-ii-alpha","display_name":"TOP2A","score":0.9139999747276306},{"id":"https://openalex.org/keywords/htert","display_name":"hTERT","score":0.871999979019165},{"id":"https://openalex.org/keywords/tep1","display_name":"TEP1","score":0.8889999985694885},{"id":"https://openalex.org/keywords/telomerase","display_name":"telomerase","score":0.984000027179718},{"id":"https://openalex.org/keywords/gene-expression","display_name":"gene expression","score":0.609000027179718},{"id":"https://openalex.org/keywords/melanoma-cell-lines","display_name":"melanoma cell lines","score":0.8650000095367432},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5189999938011169}],"concepts":[{"id":"https://openalex.org/C94581717","wikidata":"https://www.wikidata.org/wiki/Q331839","display_name":"Telomerase","level":3,"score":0.8489625453948975},{"id":"https://openalex.org/C125593758","wikidata":"https://www.wikidata.org/wiki/Q15315135","display_name":"Telomerase reverse transcriptase","level":4,"score":0.8307144641876221},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.7715378999710083},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.638611912727356},{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.5328344106674194},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.48570212721824646},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.44412869215011597},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.3712768852710724},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11534830927848816}],"mesh":[{"descriptor_ui":"D000099187","descriptor_name":"Major Vault Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002352","descriptor_name":"Carrier Proteins","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D004250","descriptor_name":"DNA Topoisomerases, Type II","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D004268","descriptor_name":"DNA-Binding Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016601","descriptor_name":"RNA-Binding Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019098","descriptor_name":"Telomerase","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D020133","descriptor_name":"Reverse Transcriptase Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D020394","descriptor_name":"Vault Ribonucleoprotein Particles","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053938","descriptor_name":"DNA Fragmentation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.3892/ijo.23.1.213","doi":"https://doi.org/10.3892/ijo.23.1.213","is_oa":false,"landing_page_url":"https://doi.org/10.3892/ijo.23.1.213","pdf_url":null,"source":{"id":"https://openalex.org/S4210208883","display_name":"International Journal of Oncology","issn_l":"1019-6439","issn":["1019-6439","1791-2423"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["dongbi-d","jufo-1","medline","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320412","host_organization_name":"Spandidos Publishing","host_organization_lineage":["https://openalex.org/P4310320412"],"host_organization_lineage_names":["Spandidos Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Oncology","raw_type":"journal-article"},{"id":"pmid:12792796","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12792796","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of oncology","raw_type":"Journal Article"},{"id":"pmh:oai:usiena-air.unisi.it:11365/21472","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11365/21472","pdf_url":null,"source":{"id":"https://openalex.org/S4377196319","display_name":"Use Siena air (University of Siena)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I102064193","host_organization_name":"University of Siena","host_organization_lineage":["https://openalex.org/I102064193"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2087123106","https://openalex.org/W1985164534","https://openalex.org/W2002088201","https://openalex.org/W2403342872","https://openalex.org/W2383749565","https://openalex.org/W176104960","https://openalex.org/W2174201576","https://openalex.org/W1991432638","https://openalex.org/W1509438164","https://openalex.org/W1979786121"],"abstract_inverted_index":{"Intrinsic":[0],"and":[1,5,25,66,86,120,129,153,184,193,205,215,227,230,233,251],"acquired":[2],"multidrug-resistance":[3],"(MDR)":[4],"the":[6,9,22,36,91,99,102,134,139,162],"activity":[7,85],"of":[8,21,26,38,81,88,101,150,181,190,261],"enzyme":[10],"telomerase":[11,27,84,93,128],"have":[12],"been":[13,44],"demonstrated":[14],"in":[15,35,57,69,79,165,197,242],"human":[16,92,243],"melanoma.":[17],"A":[18],"direct":[19],"regulation":[20],"MDR":[23,131,154,239],"pathways":[24],"by":[28,127],"interpheron-alpha":[29],"(IFN-alpha),":[30],"which":[31,68,124],"is":[32,125],"currently":[33],"used":[34,50],"therapy":[37],"advanced":[39],"cutaneous":[40],"melanoma,":[41],"has":[42],"also":[43,253],"hypothesized.":[45],"In":[46],"this":[47],"study,":[48,72],"we":[49,171],"five":[51],"melanoma":[52,244],"cell":[53,144,199,245],"lines":[54,145],"not":[55,206],"selected":[56],"vitro":[58],"for":[59,90],"drug":[60],"resistance":[61,104,108,112],"(Me665/2/21,":[62],"Me665/2/60,":[63],"HT-144,":[64],"SK-MEL-28,":[65],"SK-MEL-5),":[67],"a":[70,176,179],"previous":[71],"had":[73],"shown":[74],"different":[75],"responses":[76],"to":[77,255],"IFN-alpha":[78,169,236,262],"terms":[80],"proliferation,":[82],"apoptosis,":[83],"expression":[87,100,136,149,196],"mRNA":[89,135,159,195,217],"reverse":[94,140],"transcriptase":[95],"(hTERT).":[96],"We":[97],"investigated":[98],"multidrug":[103,107],"(MDR1)":[105],"gene,":[106],"protein":[109,113,122],"(MRP),":[110],"lung":[111],"(LRP),":[114],"topoisomerase":[115],"IIalpha":[116],"(Topo":[117],"IIalpha),":[118],"hTERT,":[119,151,182],"telomerase-associated":[121],"(TEP1),":[123],"shared":[126],"vault":[130],"proteins":[132],"at":[133],"level,":[137],"using":[138],"transcription-PCR":[141],"(RT-PCR).":[142],"All":[143],"showed":[146],"an":[147,188],"intrinsic":[148],"TEP1,":[152,191],"gene":[155,240],"transcripts":[156,241],"(only":[157],"MDR1":[158,228],"was":[160,211],"under":[161],"detection":[163],"level":[164],"SK-MEL-28":[166],"cells).":[167],"After":[168],"exposure,":[170],"observed":[172],"either":[173],"no":[174],"effect,":[175],"trend":[177],"towards":[178],"decrease":[180],"MRP,":[183],"Topo":[185],"IIalpha,":[186],"or":[187],"increase":[189],"MDR1,":[192],"LRP":[194,234,252],"some":[198],"lines.":[200,246],"Effects":[201],"were":[202,223],"usually":[203],"temporary":[204],"always":[207],"significant.":[208],"No":[209],"correlation":[210,248],"found":[212,224],"between":[213,225,231,249],"hTERT":[214],"TEP1":[216,226,232,250],"expression,":[218],"whereas":[219],"significant":[220],"positive":[221],"correlations":[222],"mRNA,":[229],"mRNA.":[235],"modulates":[237],"differently":[238],"Positive":[247],"seems":[254],"identify":[256],"them":[257],"as":[258],"common":[259],"targets":[260],"effects.":[263]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005809501","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
